International Business News - CEGE http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotech drug developer Cell Genesys Inc. reported Friday its loss widened in the second quarter, despite a major revenue infusion from a collaboration with Takeda Pharmaceuticals. http://www.ibtimes.com/articles/20080801/cell-genesys-loss-widens-in-the-second-quarter.htm Fri, 01 Aug 2008 20:26:01 EDT Cell Genesys Inc. said Tuesday that GVAX immunotherapy for prostate cancer, when used with ipilimumab, induces a cellular immune response that may be associated with a drop in prostate-specific antig... http://www.ibtimes.com/articles/20080415/cell-genesys-details-cancer-treatment-trial.htm Tue, 15 Apr 2008 13:50:30 EDT Wall Street applauded Takeda Pharmaceuticals' $8.8 billion cash bid for Millennium Pharmaceuticals, which will give the Japanese company access to a lucrative blood cancer drug and stockholders of t... http://www.ibtimes.com/articles/20080410/millennium-pharma-soars-on-takeda-bid.htm Thu, 10 Apr 2008 14:35:25 EDT Takeda Pharmaceutical Co. announced an $8.8 billion bid for U.S. biotechnology company Millennium Pharmaceuticals, an all-cash offer that would give Japan's top drug maker a key cancer treatment. T... http://www.ibtimes.com/articles/20080410/takeda-bids-8-8b-for-us-millennium.htm Thu, 10 Apr 2008 09:58:13 EDT Dendreon Corp. said Wednesday the Food and Drug Administration agreed to an accelerated timeline for its late-stage clinical trial of Provenge, the biotechnology company's prostate cancer treatment candidate. http://www.ibtimes.com/articles/20080312/dendreon-and-fda-bump-up-trial-timeline.htm Wed, 12 Mar 2008 08:52:40 EDT Among the stock activity stories for Tuesday, Feb. 19, from AP Financial News: NEW YORK (AP) _ Shares of Bucyrus International Inc. rose Tuesday, after several analysts boosted their price targets for the mining equipment maker, citing its better-than-expected financial outlook. http://www.ibtimes.com/articles/20080219/movers-roundup-bucyrus-pharmasset.htm Tue, 19 Feb 2008 14:17:15 EST Shares of Cell Genesys Inc. continued climbing Tuesday, following last week's report showing its vaccine candidate helped prostate cancer patients live longer in a midstage study. http://www.ibtimes.com/articles/20080219/cell-genesys-shares-continue-climb.htm Tue, 19 Feb 2008 13:40:43 EST Cell Genesys Inc. shares jumped Friday after the biotechnology company reported clinical test results showing that prostate cancer patients who had an immune response to one of its GVAX vaccines also lived longer. http://www.ibtimes.com/articles/20080215/cell-genesys-rises-on-gvax-trial-results.htm Fri, 15 Feb 2008 12:44:34 EST